ALGN heads into Q4 earnings with revenues likely to rise 3.9% and EPS up 22.5%, aided by Clear Aligner demand and scanner ...

Sequoia Fund discusses its new position in Align Technology and long-term outlook. Read the full Q4 2025 shareholder letter for complete portfolio insights.

Giverny Capital Asset Management, LLC, an investment management company, recently published its fourth-quarter 2025 investor ...

Align Technology, Inc. upgraded to Hold after a 30% drop; weak growth and margins persist despite guidance. Click for this ...

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign ® System of clear aligners, iTero™ ...

Tero Lumina intraoral scanner has a central role in the study's oral health data collection Align Technology, Inc. (NASDAQ: ALGN) a leading global medical device company that designs, manufactures ...

BofA raised the firm’s price target on Align Technology (ALGN) to $206 from $200 and keeps an Underperform rating on the shares. The Life Sciences Tools sector underperformed again in FY24 as Pharma ...

New professional marketing initiative celebrates the role doctors play in digital orthodontics and provides a platform to inspire others through their personal stories. Initiative underscores Align’s ...

Align stock beat on sales and beat on earnings. Foreign exchange rates alone suffice to explain most of Align's gains. Earnings are still falling, and probably free cash flow as well. Align Technology ...

Align is proud to support these students as they gather to learn, collaborate, and help bring smiles to more children." To learn more about Operation Smile's long-time partnership with Align ...